2015 – PLOS ONE study findings

Announcement Date: June 10, 2015

June 10, 2015 – Study in PLOS ONE finds up to a 21% increased risk of heart attack associated with PPI use compared to H2 blockers (Pepcid, Tagamet, Zantac).